These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Management of hepatorenal syndrome in patients with cirrhosis. Arroyo V; Fernández J Nat Rev Nephrol; 2011 Aug; 7(9):517-26. PubMed ID: 21826080 [TBL] [Abstract][Full Text] [Related]
36. Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis. Fagundes C; Ginès P Am J Kidney Dis; 2012 Jun; 59(6):874-85. PubMed ID: 22480795 [TBL] [Abstract][Full Text] [Related]
37. The Treatment of Hepatorenal Syndrome. Cavallin M; Fasolato S; Marenco S; Piano S; Tonon M; Angeli P Dig Dis; 2015; 33(4):548-54. PubMed ID: 26159272 [TBL] [Abstract][Full Text] [Related]
38. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397 [TBL] [Abstract][Full Text] [Related]
39. The natural history and management of hepatorenal disorders: from pre-ascites to hepatorenal syndrome. Blendis L; Wong F Clin Med (Lond); 2003; 3(2):154-9. PubMed ID: 12737373 [TBL] [Abstract][Full Text] [Related]